The Ghana Medical Trust Fund (GMTF) has taken another significant step toward making specialized healthcare more affordable and accessible by engaging key players in Ghana’s pharmaceutical and healthcare sectors to finalize the implementation of its Medicines List. This is a critical component designed to ensure patients receive quality treatment without crippling financial hardship.
Addressing a high-level stakeholder engagement in Accra, the Administrator of the Ghana Medical Trust Fund, Adjoa Obuobia Darko-Opoku, described the Medicines List as far more than a catalogue of drugs. She said it represents a
carefully developed national framework that will determine which medicines are financed under the Trust Fund while providing clear reimbursement prices and standardized treatment protocols to ensure transparency, consistency and accountability.
According to her, the initiative demonstrates the Trust Fund’s unwavering commitment to ensuring that no Ghanaian is denied access to life-saving medicines simply because they cannot afford them.
“The Ghana Medical Trust Fund was established to respond to one of the greatest challenges confronting healthcare in Ghana; the enormous financial burden associated with chronic and high-cost non-communicable diseases,” she stated.
She noted that every day, countless Ghanaian families are forced to exhaust their savings, sell valuable assets or resort to public appeals to finance treatment for conditions such as cancer, kidney disease and cardiovascular diseases. The Trust Fund, Obuobia Darko-Opoku explained, seeks to change that reality by ensuring access to specialized healthcare is determined by medical need rather than financial status.
Ms. Darko-Opoku revealed that the Medicines List has been developed from the revised national Standard Treatment Guidelines and Essential Medicines List for cancers, following close collaboration with the Ministry of Health. This ensures that every medicine approved under the Fund is backed by sound clinical evidence and nationally accepted treatment protocols.
She further disclosed that the Trust Fund, together with the Ministry of Health, has successfully negotiated prices for selected medicines with the objective of making treatment more affordable for patients while safeguarding value for public funds.
“This Medicines List provides certainty for patients, healthcare providers, pharmacies and suppliers. It creates a common reference point that promotes fairness, transparency and confidence across the entire healthcare delivery system,” she said.
Recognizing that financing medicines alone is not enough, the Administrator stressed that reliable medicine availability, efficient procurement systems, predictable reimbursement processes and strong partnerships across the pharmaceutical value
chain will be critical to the Trust Fund’s success.
The GMTF Boss therefore called on pharmaceutical manufacturers, suppliers, distributors, regulators, healthcare providers and development partners to work collaboratively to ensure uninterrupted availability of medicines, effective supply chain management and sustainable pricing mechanisms.
“Our responsibility is not only to establish a Trust Fund,” she emphasized. “Our responsibility is to build a financing system that is transparent, accountable, efficient and sustainable. A system that inspires confidence among patients, healthcare providers and every institution involved in its implementation.”
Ms. Darko-Opoku also highlighted the completion of the Ghana Medical Trust Fund
Tariff Operational Manual, which has received approval from the Minister for Health. She explained that the manual establishes clear procedures for service costing, claims processing, provider reimbursement and financial accountability, laying a solid operational foundation for the Trust Fund.
She maintained that the true measure of the Ghana Medical Trust Fund’s success will not lie in the number of policies or operational manuals produced but in the lives it transforms.
“The success of the Ghana Medical Trust Fund will be measured by whether a patient who needs treatment can access it at the right time, in the right place and without being overwhelmed by financial hardship,” she stated.
With the Medicines List now taking center stage,
the Ghana Medical Trust Fund says it is reinforcing its resolve to build a healthcare financing system that delivers timely access to essential medicines, eases the financial burden on vulnerable families and restores hope to thousands of Ghanaians battling life-threatening diseases.
The stakeholder engagement brought together officials from the Ministry of Health, the Food and Drugs Authority, the National Health Insurance Authority, the Ghana Health Service, teaching hospitals, pharmaceutical manufacturers, suppliers, distributors, pharmacies, development partners and professional bodies, all united by a common goal of ensuring the successful implementation of the Medicines List and strengthening access to quality healthcare across Ghana.
